One study from the Korea cohort demonstrated that the RNF213 mutant patients with MMD were associated with lower serum Cav-1 levels (10), while another study of Chung (8) did not find any difference between the RNF213 mutant and non-mutant groups, which is similar with the results of this study. This evidence concerns the gene CAV1 and multiminicore myopathy.